DNA And Gene Chip Market Size $22.37 Billion By 2030

DNA And Gene Chip Market Growth & Trends

The global DNA and gene chip market size is expected to reach USD 22.37 billion by 2030, according to a new report by Grand View Research, Inc., at a 12.3% CAGR during the forecast period. DNA and gene chips have gained much success in providing high throughput capabilities for comprehensive genome studies to enhance disease knowledge and target them. This technology has emerged as a valuable and promising solution across various aspects of disease management. These factors have been driving the market.

Conventional means of gene analysis allow investigation of relatively small amounts of genes at a time, which further emphasizes on the uptake of DNA microarray technology. DNA microarray technology allows concurrent analysis of very large numbers of nucleic acid fragments in a single experiment.

Continuous development of new tools to support and enhance the reliability of DNA microarray technology is likely to drive this market at a significant pace in the foreseeable future. Furthermore, healthcare entities are engaged in exploiting novel solutions for enhancing and combining data generated from gene chip with data generated from high throughput technologies. Mutually beneficial partnerships between microarray developers and pharmaceutical/biopharmaceutical companies for the acceleration of genomic and biomedical research activities is anticipated to spur market growth in the coming years.

 Request a free sample copy or view report summary: DNA & Gene Chip Market Report

DNA & Gene Chip Market Report Highlights

• • Based on product, consumables dominated the market with the largest share. This is due to the presence of a large number of entities engaged in providing reagents and kits associated with the use of DNA chips

• The cancer treatment and diagnosis segment accounts for a significant share in the market owing to the rising inclination toward development of companion diagnostics and growing usage of DNA microarrays in cancer diagnosis and treatment

• Implementation of gene chip for drug discovery is also expected to increase in the coming years owing to the growing demand for personalized medicine
  By end use, academic/government research institutes accounted for the largest share in 2023. Ongoing research projects on gene expression analysis in these institutes have attributed to the estimated share

• In terms of region, North America dominated the market in terms of revenue. High penetration of major revenue-generating companies in the U.S. has contributed to its leading share
  Asia Pacific is projected to witness the fastest year-on-year growth owing to rising healthcare spending in developing economies and an increase in R&D investment

DNA And Gene Chip Market Segmentation

Grand View Research has segmented the global DNA and gene chip market report based on product, type, application, end use, and region:

DNA & Gene Chip Product Outlook (Revenue, USD Million, 2018 - 2030)

• Consumables

• Instrumentation

DNA & Gene Chip Type Outlook (Revenue, USD Million, 2018 - 2030)

• Oligonucleotide DNA Microarrays

• Complementary DNA Microarrays

• BAC Clone Chips

• Others

DNA & Gene Chip Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cancer Diagnosis & Treatment

• Gene Expression

• Genotyping

• Genomics

• Drug Discovery

• Agricultural Biotechnology

• Others

DNA & Gene Chip End use Outlook (Revenue, USD Million, 2018 - 2030)

• Academic & Government Research Institutes

• Hospitals & Diagnostics Centers

• Biotechnology & Pharmaceutical Companies

• Others

DNA & Gene Chip Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in DNA And Gene Chip Market

• Thermo Fisher Scientific Inc.

• Agilent Technologies

• Illumina, Inc.

• Revvity

• Arrayit Corporation

• Macrogen, Inc.

• Asper Biotech

• CapitalBio Technology Co., Ltd.

• Greiner Bio-One International GmbH

• Microarrays Inc.,

• Biodiscovery LLC

• Oxford Gene Technology IP Limited

• TOSHIBA HOKUTO ELECTRONICS CORPORATION

• Savyon Diagnostics

• Applied Micro Arrays

• BIOMÉRIEUX